Nasdaq: CTOR/Drug Manufacturers - Specialty & Generic
Citius Oncology, Inc.
Cranford, NJ, United States
Company overview
Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. operates as a subsidiary of Leonard-Meron Biosciences, Inc.
This profile is for informational purposes only and is not investment advice. Company information may change after the verification date.